STOCK MARKET BSE NSE

20% rise in lung cancer cases reported at Amrita post lockdown

Doctors at Amrita Institute of Medical Sciences here have observed a 20% rise in the number of lung cancer patients reporting at the hospital as compared to the pre-Covid lockdown period.

Published: 11th August 2021 06:22 AM  |   Last Updated: 11th August 2021 06:22 AM   |  A+A-

MBBS exam

For representational purposes

By Express News Service

KOCHI: Doctors at Amrita Institute of Medical Sciences here have observed a 20% rise in the number of lung cancer patients reporting at the hospital as compared to the pre-Covid lockdown period. Of these, 50% have reached advanced stages as they had ignored the symptoms. Around 70% of them did not visit the hospital despite having active symptoms such as cough and mild breathing issues.

Dr Tinku Joseph K, chief of interventional pulmonology at the hospital, said at a media conference on Tuesday that lung cancer detection rates had significantly reduced during the lockdown period. “After  the restrictions were lifted, we observed a substantial surge in the number of patients visiting our OPD with advanced stages of lung cancer. Of all lung cancer patients who came to us, 70% said they had active symptoms like cough and mild breathing difficulty, but they were reluctant to visit hospitals due to the fear of getting Covid infection. Hence, we have seen a 20% rise in the number of lung cancer patients now as compared to pre-lockdown period.”

According to the National Cancer Registry of India, 27% of lung cancer cases had tobacco consumption as the main cause. Staying away from smoking and having a regular exercise routine can go a long way in preventing lung cancer. “The lack of a reliable lung cancer screening programm made the situation worse during Covid for lung cancer patients. A  significant number of people in India are smokers. We feel there is a pressing need for a structured lung cancer screening programme,” said Dr Wesley M Jose, clinical associate professor, Department of Medical Oncology and Hematology, AIMS. 



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

edexworks
flipboard facebook twitter whatsapp